Effects and Tolerability of Irbesartan Versus Enalapril in Patients With Severe Hypertension
- 15 December 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (12) , 1613-1615
- https://doi.org/10.1016/s0002-9149(97)00784-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalaprilJournal Of Hypertension, 1996
- Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertensionJournal Of Hypertension, 1996
- Controlled Multicenter Study with Quinapril, Hydrochlorothiazide, and Combination in Patients with Moderate to Severe HypertensionJournal of Cardiovascular Pharmacology, 1995
- Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertensionThe American Journal of Cardiology, 1995
- Hemodynamic and Biochemical Effects of the AT 1 Receptor Antagonist Irbesartan in HypertensionHypertension, 1995
- The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid PopulationMedical Care, 1994
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- Cough and ACE InhibitorsArchives of internal medicine (1960), 1992